Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogenn activator in acute myocardial infarction
Article Abstract:
A coronary stent plus the drug abciximab appears to be more effective for heart attack patients than tissue plasminogen activator (tPA), according to a study of 140 patients. A stent is a small cylinder that keeps an artery open, abciximab is an anticoagulant, and tPA breaks up the blood clots that cause most heart attacks.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction
Article Abstract:
The anticoagulant drug abciximab appears to improve blood flow and decrease postoperative mortality rates in heart attack patients who receive a stent. Stents are small cylindrical devices that are inserted in arteries to keep them open.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
Article Abstract:
A study is conducted enrolling 3491 patients in the age group of 18 to 75 years of age, who presented within 12 hours after the onset of an ST-elevation myocardial infarction and randomly assigned them to receive clopidogrel or placebo. In patients 75 years or younger who have myocardial infraction with ST-segment elevation, the addition of clopidogrel improves the patency rate of the infarct-related artery and reduces ischemic complications.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
- Abstracts: Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization